Need for validation of clinical decision aids: Use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C

被引:20
作者
Imperiale, TF
Said, AT
Cummings, OW
Born, LJ
机构
[1] Indiana Univ, Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA
[2] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVE: A value of greater than or equal to 1 for the ratio of aspartate aminotransferase to alanine aminotransferase (the AST/ALT ratio or AAR) has been shown to have a positive predictive value of 100% for the diagnosis of cirrhosis in patients with chronic hepatitis C. If validated on separate cohorts, an AAR greater than or equal to 1 might obviate the need for liver biopsy in some patients with hepatitis C. METHODS: We attempted to validate the AAR by abstracting demographic and clinical data from a database of consecutive patients with hepatitis C who had a liver biopsy between 1993 and 1998. We used definitions, methods of data collection, and analyses comparable to those of the published study. A hepatopathologist blindly reviewed 49 liver biopsies for histological grade and stage. RESULTS: The current cohort of 177 patients and the previous cohort of 139 patients were comparable in mean age (42.3 vs 43.8 yr), percentage of men (63 vs 67), percentage with an AAR greater than or equal to 1 (20 vs 17), and Child-Pugh distribution, but differed in substantial use of ethanol (11% vs 3.6%; p = 0.01) and in the prevalence of cirrhosis (23% vs 34%, p = 0.06). Respective sensitivities of the AAR were 56% and 53%. An AAR greater than or equal to 1 had a positive predictive value of 64% (95% confidence interval 48-78%) for the current cohort. Thirteen of 36 patients (36%) with an AAR greater than or equal to 1 were incorrectly identified as having cirrhosis. Of these 13 patients, 6 had a normal AST and ALT, 5 had a minimally elevated AST or ALT, and 1 had advanced fibrosis without cirrhosis. CONCLUSIONS: These results suggest that an AAR greater than or equal to 1 may not be as useful for predicting cirrhosis in chronic hepatitis C as previously thought, and emphasizes the need for validation of clinical decision aids on independent patient cohorts. (Am J Gastroenterol 2000;95:2328-2332. (C) 2000 by Am. Coll. of Gastroenterology).
引用
收藏
页码:2328 / 2332
页数:5
相关论文
共 23 条
[1]
Predicting clinical states in individual patients [J].
Braitman, LE ;
Davidoff, F .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (05) :406-412
[2]
WHY PREDICTIVE INDEXES PERFORM LESS WELL IN VALIDATION STUDIES - IS IT MAGIC OR METHODS [J].
CHARLSON, ME ;
ALES, KL ;
SIMON, R ;
MACKENZIE, CR .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (12) :2155-2161
[3]
SGOT-SGPT RATIO - INDICATOR OF ALCOHOLIC LIVER-DISEASE [J].
COHEN, JA ;
KAPLAN, MM .
DIGESTIVE DISEASES AND SCIENCES, 1979, 24 (11) :835-838
[4]
SGOT-SGPT RATIOS [J].
CORREIA, JP ;
ALVES, PS ;
CAMILO, EA .
DIGESTIVE DISEASES AND SCIENCES, 1981, 26 (03) :284-284
[5]
Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment [J].
Dufour, JF ;
DeLellis, R ;
Kaplan, MM .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (12) :2573-2576
[6]
Efficacy of interferon treatment for patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics, or nonfibrotics [J].
Everson, GT ;
Jensen, DM ;
Craig, JR ;
van Leeuwen, DJ ;
Bain, VG ;
Ehrinpreis, MN ;
Albert, D ;
Joh, T ;
Witt, K .
HEPATOLOGY, 1999, 30 (01) :271-276
[7]
GITLIN N, 1982, AM J GASTROENTEROL, V77, P2
[8]
HIMMELSTEIN DU, 1984, AM J GASTROENTEROL, V79, P718
[9]
HISTOLOGICAL CLASSIFICATION AND QUANTITATION OF THE SEVERITY OF CHRONIC HEPATITIS - KEEP IT SIMPLE [J].
HYTIROGLOU, P ;
THUNG, SN ;
GERBER, MA .
SEMINARS IN LIVER DISEASE, 1995, 15 (04) :414-421
[10]
Assessing the generalizability of prognostic information [J].
Justice, AC ;
Covinsky, KE ;
Berlin, JA .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :515-524